531207 RAYLA

Raymed Labs Share Price

₹2.88 0.00 (0.00%)

20 Jan, 2025 16:49

SIP TrendupStart SIP in RAYLA

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 4.73%
  • Over 3 Month + 9.92%
  • Over 6 Month + 15.2%
  • Over 1 Year + 17.07%
SIP Lightning

Smart Investing Starts Here Start SIP with Raymed Labs for Steady Growth!

Invest Now

Raymed Labs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Raymed Labs Financials

Raymed Labs Technicals

EMA & SMA

Current Price
₹2.88
0 (0%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹2.55
  • 50 Day
  • ₹2.33
  • 100 Day
  • ₹2.13
  • 200 Day
  • ₹2.35

Resistance and Support

2.88 Pivot Speed
  • R3 2.88
  • R2 2.88
  • R1 2.88
  • S1 2.88
  • S2 2.88
  • S3 2.88

What's your outlook on Raymed Labs?

You can only vote for once

Raymed Labs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-06 Quarterly Results
2024-08-12 Quarterly Results
2024-05-24 Audited Results
2024-02-06 Quarterly Results
2023-11-04 Quarterly Results

Raymed Labs F&O

Raymed Labs Shareholding Pattern

No data available.

About Raymed Labs

  • NSE Symbol
  • RAYLA
  • BSE Symbol
  • 531207
  • ISIN
  • INE741C01017

Similar Stocks to Raymed Labs

Raymed Labs FAQs

Raymed Labs share price is ₹2 As on 20 January, 2025 | 16:35

The Market Cap of Raymed Labs is ₹1.2 Cr As on 20 January, 2025 | 16:35

The P/E ratio of Raymed Labs is -11.6 As on 20 January, 2025 | 16:35

The PB ratio of Raymed Labs is -0.5 As on 20 January, 2025 | 16:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23